MNBP yields 1.61% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, MNBP + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MNBP + PFE for your $10,000?
Mars Bancorp, Inc., through its subsidiaries, provides banking products and services for individuals and businesses in Pennsylvania. Its deposit products include checking, statement and passbook savings, NOW, and money market accounts; and certificates of deposit. The company also offers residential mortgages; commercial mortgages comprising loans to commercial customers for self-use or income-producing commercial or residential real estate; commercial and industrial loans to finance the activities of commercial customers; auto and personal loans; home equity and small business loans; mortgage refinance; and commercial lines of credit and letter of credit, as well as credit cards and investment securities. In addition, its commercial banking services include business loans/borrowings, treasury management, merchant, and public/municipal financing services. Further, the company provides real estate settlement services and title insurance products; remote deposit capture, wire transfers, automated clearing house, positive pay, and line of credit sweep services; and online and mobile banking services. It operates through six branch offices located in the areas of Allegheny, Butler, and Mercer counties in Western Pennsylvania. The company was formerly known as Mars National Bancorp, Inc. and changed its name to Mars Bancorp, Inc. in June 2017. Mars Bancorp, Inc. was founded in 1900 and is headquartered in Mars, Pennsylvania.
Full MNBP Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.